News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

First Genetic Trust, Inc. To Provide IT System To Support Prolonged QT Research At Vanderbilt University Medical Center


10/19/2005 5:12:24 PM

CHICAGO--(BUSINESS WIRE)--Jan. 17, 2005--First Genetic Trust, Inc., (FGT) and the Vanderbilt University Medical Center (VUMC) announced today that FGT will provide its web-based enTRUST(R) Study Management system to expand VUMC's studies of the genetics of drug-induced Prolonged QT, a side-effect for many different classes of drugs. Patients who exhibit Prolonged QT may develop heart arrhythmias that can lead to sudden death in some cases.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES